Editorial
The management of sepsis: science & fiction
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S1-S4
.
(01 February 2020)
Review Article
Role of procalcitonin use in the management of sepsis
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S5-S15
.
(01 February 2020)
The complete blood count to diagnose septic shock
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S16-S21
.
(01 February 2020)
Driving blind: instituting SEP-1 without high quality outcomes data
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S22-S36
.
(01 February 2020)
Fluid resuscitation in sepsis: the great 30 mL per kg hoax
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S37-S47
.
(01 February 2020)
The origins of the Lacto-Bolo reflex: the mythology of lactate in sepsis
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S48-S53
.
(01 February 2020)
Melatonin for the treatment of sepsis: the scientific rationale
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S54-S65
.
(01 February 2020)
Timeliness of antibiotics for patients with sepsis and septic shock
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S66-S71
.
(01 February 2020)
Early norepinephrine use in septic shock
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S72-S77
.
(01 February 2020)
Thiamine (vitamin B1) in septic shock: a targeted therapy
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S78-S83
.
(01 February 2020)
Vitamin C: an essential “stress hormone” during sepsis
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S84-S88
.
(01 February 2020)
Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S89-S100
.
(01 February 2020)
Time to stop randomized and large pragmatic trials for intensive care medicine syndromes: the case of sepsis and acute respiratory distress syndrome
Journal of Thoracic Disease
2020;
12
(Suppl 1)
:S101-S109
.
(01 February 2020)
Disclosure:
This supplement “Sepsis: Science and Fiction” was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding. Paul E. Marik served as the unpaid Guest Editor for the supplement.
